Latest News
US pre-open: Heavy losses seen as US-China relations deteriorate further
US futures pointed to heavy losses on Wall Street on Tuesday as relations between the US and China took another turn for the worse.
London midday: Stocks pare losses as Brexit woes hit pound; profit warnings weigh
London stocks had pared losses by midday on Tuesday as Brexit worries weighed on the pound, but escalating tensions between the US and China and a series of profit warnings kept investors on edge.
Regulator blasts water companies for winter leak failings
Regulator Ofwat has criticized water providers Thames Water, South East Water, Southern Water and Severn Trent for their poor handling of water supplies during the ‘Beast from the East’ earlier this year.
Significant policy accommodation "still needed", ECB's Draghi says
European Central Bank chief Mario Draghi sounded a confident note on the outlook for inflation on Tuesday, despite the multiple sources of uncertainty surrounding the outlook for growth.
Eurozone construction output improves
Eurozone construction output is growing more strongly, official data showed on Tuesday, indicating the second quarter will make a good recovery from an extremely slow start to the year.
German economic growth forecasts slashed over trade war fears
Germany's economy is expected to grow more slowly in the coming years due to the risks around a euro crisis sparked by Italy and a potential trade war with the US.
Flybe full-year losses narrow
Flybe said on Tuesday that its pre-tax loss narrowed in the year to the end of March 2018 as revenue and passenger numbers rose.
Roche to acquire Nasdaq-listed Foundation Medicine
Roche announced on Tuesday that it has entered into a definitive merger agreement with Nasdaq-listed Foundation Medicine, for Roche to acquire the outstanding shares of Foundation’s common stock not already owned by Roche and its affiliates, at a price of $137 per share in cash.
Alliance Pharma buys Asia-Pacific rights to Nizoral dandruff shampoo
Speciality pharmaceutical company Alliance Pharma has agreed to acquire exclusive marketing rights to medical anti-dandruff shampoo brand Nizoral in the Asia-Pacific region from Johnson & Johnson subsidiary Janssen Pharmaceutica, it announced on Tuesday, for a total consideration of £60m.
FastForward pours $2m into ageing therapy firm Juvenescence
FastForward Innovations has subscribed $2m for an approximate 0. 8% equity interest in Juvenescence, a British Virgin Islands incorporated private company developing therapies to slow, halt and potentially reverse ageing, it announced on Tuesday.
Irish Continental gets new EUR 80m facility to help pay for new ferries
Irish Continental Group has concluded an additional financing facility with the European Investment Bank, it announced on Tuesday.
Ubisense signs contract for military training
Ubisense shares jumped after the enterprise location intelligence company said it had signed a military training contract in North America.
Strategic Minerals feels 'justified' after Australian exploration programme
Production and development firm Strategic Minerals said "a number" of targets for further investigation were identified from initial tests of its gold, nickel and rare earth element exploration projects in Australia.
Hammond warns NHS boost leaves no money for schools or defence
Chancellor Philip Hammond warned ministers that the NHS £25bn a year rise in NHS spend by 2023 would leave no extra cash for defence and policing, though the Prime Minister is thought to be prepared to go against manifesto pledges and sanction tax rises.
Footasylum tumbles as it warns on earnings
Shares in Footasylum nosedived after the footwear and apparel retailer reported a rise in full-year earnings but warned that earnings for this year would be hit by increased investment in its stores and website on what was turning out to be a bad day for retailers, with department store chain Debenhams warning on profit.
Europe open: Stocks skid lower in early trading
Europe's main equity gauges skidded lower in early trading on the back of the White House's threat of fresh tariffs on up to $400bn-worth of Chinese goods.
Taptica carries growth momentum into new trading year
Advertising technology specialist Taptica has raised expectations for full-year profits as the sales momentum of last year carried over into 2018.
Frontier IP scoops 24% stake in James Dean's material testing firm
Intellectual property firm Frontier IP Group on Tuesday confirmed that it has acquired a 24% stake in mechanics and material deformation company Cambridge Material Testing Solutions (CMTS).
Telecom Plus profits edge up amid tough energy market
Telecom Plus reported a slight increase in annual profit as the utility company grappled with tough trading conditions in the energy market.
Syncona commits another £85m to Freeline
Healthcare investing company Syncona has committed £85m to Freeline in an £88. 4m Series B financing, it announced on Tuesday.